Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2022-05-05 Share Issue/Capital Cha…
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomed Oyj toteutti onnistuneesti suunnatun osakeannin keräten 4,8 miljoonaa euroa
Share Issue/Capital Change Classification · 98% confidence The document text explicitly details a 'suunnattu osakeanti' (directed share issue) where Optomed Oyj decided to issue new shares to institutional and experienced investors, raising approximately 4.8 million euros. The text outlines the terms, pricing (3.45 euros per share), the purpose (funding growth strategy, especially in the US diabetic retinopathy screening market), and the expected registration/trading dates. This content directly relates to the company raising capital and changing its share structure through a new issuance, which aligns perfectly with the 'Capital/Financing Update' definition. It is not a general earnings release (ER), an annual report (10-K), or a simple announcement of a report (RPA).
2022-05-05 Finnish
05056722.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report, January – March 2022' for Optomed Plc. It contains comprehensive financial statements, including revenue, EBITDA, operating results, cash flow, and segment-specific performance data for the first quarter of 2022. It is not a mere announcement or certification, but the full interim financial report itself, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-05 English
Optomed Plc: Interim Report, January – March 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Optomed Plc: Interim Report, January – March 2022'. It contains detailed financial statements, including revenue, EBITDA, operating results, cash flow, and segment-specific performance data for the first quarter of 2022. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-05 English
05056721.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Osavuosikatsaus Tammi - Maaliskuu 2022' (Interim Report January-March 2022) for Optomed Oyj. It contains detailed financial statements, key performance indicators (KPIs), segment analysis (Devices and Software), management commentary, and financial position data for the first quarter of 2022. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2022
2022-05-05 Finnish
Optomed Oyj:n osavuosikatsaus,tammi-maaliskuu 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Optomed Oyj:n osavuosikatsaus, tammi-maaliskuu 2022' (Optomed Oyj Interim Report, January-March 2022). It contains comprehensive financial data, including income statements, balance sheet items, segment reporting (Devices and Software), and management commentary for the first quarter of 2022. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-05 Finnish
Optio-ohjelma 2017B (ehdotetuin muutoksin).pdf
Governance Information Classification · 95% confidence The document outlines the terms and conditions of a stock option program (Optio-ohjelma) for Optomed Oyj. It details the rules for granting options, subscription prices, exercise periods, and handling of options in special situations like M&A or takeovers. This type of document is a formal governance and incentive plan disclosure, which falls under the category of Governance Information (CGR) as it defines the internal rules and structures regarding equity-based compensation.
2022-04-07 Finnish

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.